Xinguang Pharmaceutical (300519.SZ) announced first-half results, with net profit of 397.12,100 yuan to mother, an increase of 24.46% over the previous year

According to the Zhitong Finance App, Xinguang Pharmaceutical (300519.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 143 million yuan, an increase of 1.17% over the previous year. Achieved net profit of 397.121 million yuan attributable to shareholders of listed companies, an increase of 24.46% over the previous year. Achieved net profit of 36.2094 million yuan after deducting non-recurring profit and loss attributable to shareholders of listed companies, an increase of 23.00% over the previous year.